Showing results (81-90 of 128) with videos related to
Sort By:
Pageof 13
Blood Advances|October 1, 2021
CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trialsChezi Ganzel, Ju-Whei Lee, Hugo F Fernandez, et al.Blood|October 24, 2002
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocolMartin S Tallman, Janet W Andersen, Charles A Schiffer, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 5, 2021
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2Joseph I Clark, Brendan Curti, Elizabeth J Davis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2016
Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008Chezi Ganzel, Judith Manola, Dan Douer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2008
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphomaPeter H Wiernik, Izidore S Lossos, Joseph M Tuscano, et al.Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.Blood|August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.Leukemia Research|March 27, 2013
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129Dan Douer, Lynette N Zickl, Charles A Schiffer, et al.The Journal of Experimental Medicine|December 14, 2011
ETV6 mutations in early immature human T cell leukemiasPieter Van Vlierberghe, Alberto Ambesi-Impiombato, Arianne Perez-Garcia, et al.American Journal of Hematology|June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experienceChezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.Pageof 13